Syros Pharmaceuticals announced the appointment of Michael W. Bonney to the Company’s Board of Directors. Mr. Bonney brings extensive strategic, operational, commercial and leadership experience in the biotechnology industry. Mr. Bonney is currently chief executive officer and chair of the board of Kaleido Biosciences. Previously, Mr. Bonney was chief executive officer and director of Cubist Pharmaceuticals from 2003 until 2014. Mr. Bonney chairs the boards of Alnylam Pharmaceuticals and Magenta Therapeutics and serves on the boards of Celgene Corporation and Sarepta Therapeutics. He is chair of the board of trustees of Bates College and a member of the board of the Whitehead Institute for Biomedical Research. The company also announced that Robert Nelson and Sanj K. Patel have stepped down from the company’s board of directors.